Table 2. Plasma levels of complement components in different pathological variants of primary FSGS patients.

Pathological variant	Plasma levels of complement components (median, IQR)
	C1q (μg/ml)	MBL (ng/ml)	Bb (μg/ml)	C4d (μg/ml)	C3a (ng/ml)	C5a (ng/ml)	C5b-9 (ng/ml)
Tip variants	76.31	106.16	0.57	13.82	512.12	9.60	392.64
(n = 23)	(71.35–88.87)	(55.70–217.56)	(0.39–0.77)	(10.51–20.19)	(133.01–954.44)	(7.00–11.68)	(318.21–497.38)
Nos variants	84.10	96.36	0.57	16.27	497.85	9.11	336.13
(n = 23)	(73.24–104.22)	(34.02–180.32)	(0.37–0.79)	(11.61–21.74)	(357.27–1062.41)	(6.18–19.81)	(267.21–180.32)
Cellular variants	66.80	99.49	0.55	13.78	654.57	13.90	513.92
(n = 21)	(58.49–8369)	(40.50–170.25)	(0.31–1.18)	(10.16–18.55)	(339.52–1056.99)	(9.00–17.99)	(376.10–784.76)
P value
Total	0.022	0.548	0.995	0.699	0.643	0.132	0.003
tip vs. NOS	0.132						0.047
tip vs. cellular	0.181						0.076
NOS vs. cellular	0.006						0.001

IQR: inter-quartile range; NOS: not otherwise specified.